Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US
作者： J. Mark Stephens , Xiaoyan Li , Maureen Reiner , Spiros Tzivelekis
DOI: 10.3111/13696998.2016.1140052
关键词:
摘要: AbstractObjective:Prophylactic treatment with granulocyte-colony stimulating factors (G-CSFs) is indicated for chemotherapy patients a significant risk of febrile neutropenia. This study estimates the annual economic burden on and caregivers clinic visits prophylactic G-CSF injections in US.Methods:Annual (all cancers) were estimated from national cancer incidence, utilization data, sales pricing information. Patient travel times, plus time spent clinic, patient survey responses collected during large prospective cohort (the Prospective Study Relationship between Chemotherapy Dose Intensity Mortality Early-Stage (I–III) Breast Cancer Patients). Economic models created to estimate costs, co-pays value by visits.Results:Estimated total fo...
sci-hub.se 参考文章(52)
Jeffrey J. Guidry, Rodger J. Winn, Lu Ann Aday, Dong Zhang, Transportation as a barrier to cancer treatment. Cancer Practice. ,vol. 5, pp. 361- 366 ,(1997)
Gary H. Lyman, Sally C. Stearns, William R. Carpenter, Suja S. Rajan, Short-term costs associated with primary prophylactic G-CSF use during chemotherapy. The American Journal of Managed Care. ,vol. 19, pp. 150- 159 ,(2013)
Justin G Trogdon, Susan A Sabatino, Florence K Tangka, Lisa C Richardson, Eric A Finkelstein, The Personal Financial Burden of Cancer for the Working-Aged Population The American Journal of Managed Care. ,vol. 15, pp. 801- 806 ,(2009)
Lyen C. Huang, Yifei Ma, Justine V. Ngo, Kim F. Rhoads, What factors influence minority use of National Cancer Institute-designated cancer centers? Cancer. ,vol. 120, pp. 399- 407 ,(2014) , 10.1002/CNCR.28413
Amy J. Davidoff, Mujde Erten, Thomas Shaffer, J. Samantha Shoemaker, Ilene H. Zuckerman, Naimish Pandya, Ming-Hui Tai, Xuehua Ke, Bruce Stuart, Out‐of‐pocket health care expenditure burden for Medicare beneficiaries with cancer Cancer. ,vol. 119, pp. 1257- 1265 ,(2013) , 10.1002/CNCR.27848
Jeffrey Crawford, David C. Dale, Nicole M. Kuderer, Eva Culakova, Marek S. Poniewierski, Debra Wolff, Gary H. Lyman, Risk and Timing of Neutropenic Events in Adult Cancer Patients Receiving Chemotherapy: The Results of a Prospective Nationwide Study of Oncology Practice Journal of The National Comprehensive Cancer Network. ,vol. 6, pp. 109- 118 ,(2008) , 10.6004/JNCCN.2008.0012
Rinaa S. Punglia, Jane C. Weeks, Bridget A. Neville, Craig C. Earle, Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women International Journal of Radiation Oncology*Biology*Physics. ,vol. 66, pp. 56- 63 ,(2006) , 10.1016/J.IJROBP.2006.03.059
Gisoo Barnes, Ashutosh Pathak, Lee Schwartzberg, G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use. Cancer Medicine. ,vol. 3, pp. 1477- 1484 ,(2014) , 10.1002/CAM4.344
Derek Weycker, Richard Barron, Alex Kartashov, Jason Legg, Gary H Lyman, Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings: Journal of Oncology Pharmacy Practice. ,vol. 20, pp. 190- 198 ,(2014) , 10.1177/1078155213492450
Terry Meden, Celeste St. John-Larkin, Deborah Hermes, Stephen Sommerschield, Relationship Between Travel Distance and Utilization of Breast Cancer Treatment in Rural Northern Michigan JAMA. ,vol. 287, pp. 111- 111 ,(2002) , 10.1001/JAMA.287.1.111-JMS0102-5-1